Polypharmacy in Home Care in Europe: Cross-Sectional Data from the IBenC Study.

Silvia GiovanniniHenriëtte G van der RoestAngelo CarfìHarriet Finne-SoveriVjenka Garms-HomolováAnja DeclercqPálmi V JónssonHein van HoutDavide L VetranoEster Manes GravinaRoberto BernabeiGraziano Onder

Published in: Drugs & aging (2018)

Polypharmacy and excessive polypharmacy are common among HC patients in Europe. Factors associated with polypharmacy status include not only co-morbidity but also specific symptoms and age.

Keyphrases

cross sectional
end stage renal disease
adverse drug
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
electronic health record
weight gain
body mass index
machine learning
physical activity
weight loss
data analysis